EKSCX
Price
$6.82
Change
-$0.05 (-0.73%)
Updated
Jul 13 closing price
Net Assets
548.51M
HBLAX
Price
$14.91
Change
-$0.01 (-0.07%)
Updated
Jul 13 closing price
Net Assets
11.12B
Interact to see
Advertisement

EKSCX vs HBLAX

EKSCX vs HBLAX Comparison Chart in %
View a ticker or compare two or three
VS
EKSCX vs. HBLAX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EKSCX is a Buy and HBLAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HBLAX has more cash in the bank: 11.1B vs. EKSCX (549M). EKSCX pays higher dividends than HBLAX: EKSCX (3.88) vs HBLAX (3.18). EKSCX was incepted earlier than HBLAX: EKSCX (33 years) vs HBLAX (20 years). EKSCX (1.85) is less costly to investors than HBLAX (0.89). HBLAX is a more actively managed with annual turnover of: 90.00 vs. EKSCX (83.00). EKSCX has a lower initial minimum investment than HBLAX: EKSCX (1000) vs HBLAX (2000). HBLAX IRA initial investment is lower compared to EKSCX: HBLAX (2000) vs EKSCX (250). EKSCX annual gain was more profitable for investors over the last year : 12.84 vs. HBLAX (4.94). EKSCX return over 5 years is better than : 27.91 vs. HBLAX (6.11).
EKSCXHBLAXEKSCX / HBLAX
Total Expense Ratio1.590.89179%
Annual Report Gross Expense Ratio1.850.89208%
Fund Existence33 years20 years-
Gain YTD5.5404.286129%
Front LoadN/A6%-
Min. Initial Investment1000200050%
Min. Initial Investment IRA250200013%
Net Assets549M11.1B5%
Annual Yield % from dividends3.883.18122%
Returns for 1 year12.844.94260%
Returns for 3 years40.0218.62215%
Returns for 5 years27.916.11457%
Returns for 10 years56.9037.99150%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ITW271.502.69
+1.00%
Illinois Tool Works
WTM2174.96-6.23
-0.29%
White Mountains Insurance Group Ltd
EYPT14.28-0.44
-2.99%
EyePoint Inc.
LTRX5.31-0.29
-5.18%
Lantronix
CLRB2.63-0.19
-6.74%
Cellectar Biosciences Inc